Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-23-047253
Filing Date
2023-10-06
Accepted
2023-10-06 08:05:43
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A ny20010238x2_defa14a.htm DEFA14A 16985
2 ny200010238x2_nc01.jpg GRAPHIC 390221
3 ny200010238x2_nc02.jpg GRAPHIC 258121
  Complete submission text file 0001140361-23-047253.txt   911367
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-31791 | Film No.: 231312640
SIC: 2834 Pharmaceutical Preparations